Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
ShedRx offers one of the widest medication selections, including GLP-1 and non-GLP-1 options, both compounded and brand-name, across multiple formats
A clinical trial involving over 600 adults with obesity showed that those who took the injectable form for 68 weeks lost an average of 15.3% of their body weight, compared to 12.4% with oral Semaglutide GLP-1
Constipation affects a meaningful percentage of tirzepatide users at all doses
Comparative analysis revealed that oral administration is more likely to induce gastrointestinal disorders such as pancreatitis, pancreatic cancer, belching, gastric emptying disorders, and gallstones when compared to subcutaneous injection
Clinical Trial Data (SURMOUNT-1): The data on weight loss percentages for Mounjaro (tirzepatide) was sourced from the SURMOUNT-1 clinical trial, which studied the medications effects in adults with obesity or overweight without diabetes
Frequently Asked Questions Research & Laboratory Notice These products are intended strictly for laboratory and educational purposes
US$ 20.66
US$ 20.70
US$ 26.23
US$ 28.98
US$ 26.62
US$ 24.06
US$ 28.61
US$ 29.36
US$ 28.58
US$ 26.27
